Napoleone Ferrara - Mar 18, 2025 Form 3 Insider Report for Kalaris Therapeutics, Inc. (KLRS)

Role: Director
Signature: /s/ Andrew Oxtoby, Attorney-in-Fact
Stock symbol: KLRS
Transactions as of: Mar 18, 2025
Transactions value $: $0
Form type: 3
Date filed: 3/18/2025, 05:27 PM
Next filing: Apr 11, 2025
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney